Introduction to Basics of Pharmacology and Toxicology Volume 4: Pharmacology and Therapeutics /

This Book is the 4th and final volume of the series under the title, “Introduction to Basics of Pharmacology and Toxicology” – with a primary focus on clinical pharmacology and therapeutics aspects. The initial and major part of this volume provides an extensive description of the use of drugs in cl...

Повний опис

Збережено в:
Бібліографічні деталі
Співавтор: SpringerLink (Online service)
Інші автори: Arivazhahan, Avinash (Редактор), Shah, Neel (Редактор), Sandhiya, Selvarajan (Редактор), Raj, Gerard Marshall (Редактор)
Формат: Електронний ресурс eКнига
Мова:Англійська
Опубліковано: Singapore : Springer Nature Singapore : Imprint: Springer, 2025.
Редагування:1st ed. 2025.
Предмети:
Онлайн доступ:https://doi.org/10.1007/978-981-95-1920-0
Теги: Додати тег
Немає тегів, Будьте першим, хто поставить тег для цього запису!

MARC

LEADER 00000nam a22000005i 4500
001 978-981-95-1920-0
003 DE-He213
005 20260810162834.0
007 cr nn 008mamaa
008 251103s2025 si | o |||| 0|eng d
020 |a 9789819519200  |9 978-981-95-1920-0 
024 7 |a 10.1007/978-981-95-1920-0  |2 doi 
050 4 |a R850.A1-854 
050 4 |a QH315-320 
072 7 |a MBGR  |2 bicssc 
072 7 |a MED106000  |2 bisacsh 
072 7 |a MBGR  |2 thema 
082 0 4 |a 610.72  |2 23 
245 1 0 |a Introduction to Basics of Pharmacology and Toxicology  |h [electronic resource] :  |b Volume 4: Pharmacology and Therapeutics /  |c edited by Avinash Arivazhahan, Neel Shah, Selvarajan Sandhiya, Gerard Marshall Raj. 
250 |a 1st ed. 2025. 
264 1 |a Singapore :  |b Springer Nature Singapore :  |b Imprint: Springer,  |c 2025. 
300 |a 1 online resource (XXVII, 547 p. 62 illus.).  |b 52 illus. in color. 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
341 0 |b PDF/UA-1  |2 onix 
341 0 |b Table of contents navigation  |2 onix 
341 0 |b Single logical reading order  |2 onix 
341 0 |b Short alternative textual descriptions  |2 onix 
341 0 |b Use of color is not sole means of conveying information  |2 onix 
341 0 |b Use of high contrast between text and background color  |2 onix 
341 0 |b Next / Previous structural navigation  |2 onix 
341 0 |b All non-decorative content supports reading without sight  |2 onix 
347 |a text file  |b PDF  |2 rda 
505 0 |a 1. Clinical Pharmacokinetics -- 2. Essential medicines and rational use of drugs -- 3. Drug Information Centre -- 4. Evidence-Based Medicine -- 5. Medication Adherence -- 6. Therapeutic Drug Monitoring -- 7. Medication Error -- 8. Drug use in pregnancy and lactation (Perinatal pharmacology) -- 9. Pediatric Pharmacology -- 10. Geriatric Pharmacology -- 11. Usage of drugs in various Pathological States -- 12. High throughput screening and computer-aided drug designing -- 13. Phase 0 Clinical Trials -- 14. Phase 1 Clinical Trials -- 15. Phase 2 Clinical Trials -- 16. Phase 3 Clinical Trials -- 17. Phase 4 Clinical trials -- 18. Ethics in Clinical Trials -- 19. Vaccine Clinical Trials -- 20. Real-World Evidence Studies and Pragmatic Clinical Trials -- 21. Contract Research Organizations - Roles & Responsibilities -- 22. Bioavailability and Bioequivalence Studies -- 23. New Drugs and Clinical trial rules 2019 -- 24. Regulation of healthcare products by the United States Food and Drug Administration and Health Canada -- 25. Regulation of healthcare products by the United States Food and Drug Administration and Health Canada -- 26. Medical Device and Medical Device Regulations -- 27. Off-Label Use of Drugs -- 28. Nonclinical testing methods to assess safety and efficacy of new drugs -- 29. Novel Chemical and Biological Entities in the Past Five Years -- 30. Drug Repurposing -- 31. Specialized Drug Delivery System -- 32. Biologicals and Biosimilars. 
520 |a This Book is the 4th and final volume of the series under the title, “Introduction to Basics of Pharmacology and Toxicology” – with a primary focus on clinical pharmacology and therapeutics aspects. The initial and major part of this volume provides an extensive description of the use of drugs in clinical practice – with a clear and accessible overview of all the key prescribing topics needed for clinicians and researchers involved in the pharmacology segment. Emphasizing the safe and effective administration of drugs, this volume helps readers understand the principles of clinical pharmacology to prevent medication errors. This title is also intended for researchers involved in clinical trials and developing a protocol. It is highly significant for practitioners who must critically analyze the literature of published clinical trials and assess the benefits of each trial, as well as its implications for patient care and treatment. A chapter on clinical trial ethics has been included and presented in a well-organized and sequential manner. Problems related to drug use in paediatrics, geriatric, and perinatal pharmacology have also been introduced as separate chapters. Researchers are introduced to the regulatory framework and the critical guidelines they must follow to meet agency approval standards. Full of numerous examples and the latest drug regulation guidelines, makes this volume a must have resource for all early, mid-career and senior clinicians as well as researchers. This is a highly informative and carefully presented book, providing scientific insights for scholars with an interest in clinical pharmacology. 
532 8 |a Accessibility summary: This PDF has been created in accordance with the PDF/UA-1 standard to enhance accessibility, including screen reader support, described non-text content (images, graphs), bookmarks for easy navigation, keyboard-friendly links and forms and searchable, selectable text. We recognize the importance of accessibility, and we welcome queries about accessibility for any of our products. If you have a question or an access need, please get in touch with us at accessibilitysupport@springernature.com. Please note that a more accessible version of this eBook is available as ePub. 
532 8 |a No reading system accessibility options actively disabled 
532 8 |a Publisher contact for further accessibility information: accessibilitysupport@springernature.com 
588 |a Print version record. 
650 0 |a Medicine  |x Research. 
650 0 |a Biology  |x Research. 
650 0 |a Ethics. 
650 0 |a Pharmacy. 
650 0 |a Pharmacovigilance. 
650 1 4 |a Biomedical Research. 
650 2 4 |a Moral Philosophy and Applied Ethics. 
650 2 4 |a Pharmacy. 
650 2 4 |a Drug Safety and Pharmacovigilance. 
700 1 |a Arivazhahan, Avinash.  |e editor.  |4 edt  |4 http://id.loc.gov/vocabulary/relators/edt 
700 1 |a Shah, Neel.  |e editor.  |4 edt  |4 http://id.loc.gov/vocabulary/relators/edt 
700 1 |a Sandhiya, Selvarajan.  |e editor.  |4 edt  |4 http://id.loc.gov/vocabulary/relators/edt 
700 1 |a Raj, Gerard Marshall.  |e editor.  |0 (orcid)0000-0001-7499-7219  |1 https://orcid.org/0000-0001-7499-7219  |4 edt  |4 http://id.loc.gov/vocabulary/relators/edt 
710 2 |a SpringerLink (Online service) 
773 0 |t Springer Nature eBook 
776 0 8 |i Printed edition:  |z 9789819519194 
776 0 8 |i Printed edition:  |z 9789819519217 
776 0 8 |i Printed edition:  |z 9789819519224 
856 4 0 |u https://doi.org/10.1007/978-981-95-1920-0 
912 |a ZDB-2-SBL 
912 |a ZDB-2-SXB 
912 |a ZDB-2-237 
950 |a Biomedical and Life Sciences (SpringerNature-11642) 
950 |a Biomedical and Life Sciences (R0) (SpringerNature-43708) 
950 |a Focus Bundle Biomedical and Human Health Sciences (SpringerNature-85407)